Alliancebernstein L.P. Novavax Inc Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Novavax Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 163,213 shares of NVAX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,213

Previous 163,213 -0.0%

Holding current value

$1.15 Million

Previous $1.31 Million 20.27%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $200,268 - $1.08 Million	51,483 Added 46.08%	163,213 $2.07 Million
Q1 2024 May 14, 2024	SELL	$3.76 - $6.02 $2,455 - $3,931	-653 Reduced 0.58%	111,730 $534,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $22,521 - $35,987	-4,692 Reduced 4.01%	112,383 $539,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $22,466 - $32,132	3,299 Added 2.9%	117,075 $847,000
Q2 2023 Aug 15, 2023	BUY	$6.67 - $9.52 $264,058 - $376,887	39,589 Added 53.36%	113,776 $845,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $235,445 - $510,132	40,876 Added 122.71%	74,187 $514,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $124 - $350	14 Added 0.04%	33,311 $342,000
Q3 2022 Nov 15, 2022	SELL	$18.2 - $76.12 $929,965 - $3.89 Million	-51,097 Reduced 60.55%	33,297 $606,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $1.1 Million - $2.27 Million	30,216 Added 55.77%	84,394 $4.34 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $1.37 Million - $2.8 Million	19,577 Added 56.58%	54,178 $3.99 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.54 Million - $2.49 Million	-11,420 Reduced 24.81%	34,601 $4.95 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $283,235 - $431,033	1,593 Added 3.59%	46,021 $9.54 Million
Q2 2021 Jul 30, 2021	SELL	$121.0 - $257.67 $7.51 Million - $16 Million	-62,061 Reduced 58.28%	44,428 $9.43 Million
Q1 2021 May 06, 2021	BUY	$112.98 - $319.93 $2.22 Million - $6.29 Million	19,661 Added 22.64%	106,489 $19.3 Million
Q4 2020 Feb 08, 2021	SELL	$78.74 - $139.5 $1.4 Million - $2.48 Million	-17,762 Reduced 16.98%	86,828 $9.68 Million
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $226,404 - $508,753	-2,850 Reduced 2.65%	104,590 $11.3 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $679,140 - $4.1 Million	49,000 Added 83.85%	107,440 $8.96 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $91,962 - $374,400	23,400 Added 66.78%	58,440 $794,000
Q4 2019 Feb 18, 2020	SELL	$3.69 - $5.22 $1,040 - $1,472	-282 Reduced 0.8%	35,040 $139,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $174,137 - $430,928	35,322 New	35,322 $207,000

Others Institutions Holding NVAX

# of Institutions

299

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $550M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Novavax Inc Transaction History